Patents Assigned to Coagulant Therapeutics Corporation
  • SHORT-ACTING FACTOR VII POLYPEPTIDES
    Publication number: 20230295596
    Abstract: Short-acting Factor VII peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders. Modification of the sialylation and/or glycosylation of Factor VII and variants thereof produced peptides useful in treating conditions of acute bleeding.
    Type: Application
    Filed: November 8, 2022
    Publication date: September 21, 2023
    Applicant: COAGULANT THERAPEUTICS CORPORATION
    Inventors: Maxine BAUZON, Terry HERMISTON
  • Short-acting Factor VII polypeptides
    Patent number: 11530401
    Abstract: Short-acting Factor VII peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders. Modification of the sialylation and/or glycosylation of Factor VII and variants thereof produced peptides useful in treating conditions of acute bleeding.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: December 20, 2022
    Assignee: Coagulant Therapeutics Corporation
    Inventors: Maxine Bauzon, Terry Hermiston
  • SHORT-ACTING FACTOR VII POLYPEPTIDES
    Publication number: 20210002624
    Abstract: Short-acting Factor VII peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders. Modification of the sialylation and/or glycosylation of Factor VII and variants thereof produced peptides useful in treating conditions of acute bleeding.
    Type: Application
    Filed: June 9, 2020
    Publication date: January 7, 2021
    Applicant: Coagulant Therapeutics Corporation
    Inventors: Maxine Bauzon, Terry Hermiston
  • Short-acting factor VII polypeptides
    Patent number: 10717970
    Abstract: Short-acting Factor VII peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders. Modification of the sialylation and/or glycosylation of Factor VII and variants thereof produced peptides useful in treating conditions of acute bleeding.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: July 21, 2020
    Assignee: Coagulant Therapeutics Corporation
    Inventors: Maxine Bauzon, Terry Hermiston